By Alex Benfield On December 2, 202104:00 PM Eastern
The holiday season has got me sentimental. So today let’s take a look back at 2021 to celebrate just how far we’ve come this year ... and then look ahead to what’s next.
By Jon D. Markman On December 2, 202102:45 PM Eastern
Stocks jumped midday Thursday with financials and energy in the lead, while crude oil futures rose. The Dow Jones Industrial Average (DJIA) jumped 1.9% to 34,678.10, with the S&P 500 up by 1.7%...
By Kelly Green On December 2, 202107:00 AM Eastern
Hunting for one last ingredient led me to the Weiss Ratings website and a search for companies with grocery delivery.
Strategic Options
Subscription
By Jon D. Markman On December 2, 202106:30 AM Eastern
Every year, traders anxiously await the first data on Thanksgiving retail sales. The information shapes analyst models and investment narratives. This year, online sales were flat throughout...
By Alex Benfield On December 1, 202105:02 PM Eastern
Ethereum is flexing its muscles as it attempts to lead the market yet again today. And select altcoins are following with significant strength.
By Marko Grujic On December 1, 202103:51 PM Eastern
Now that you’ve conquered my Starter Level and Level 1 yield hunter strategies, it’s time to move on to Level 2 and the even higher yields it offers.
By Jon D. Markman On December 1, 202102:16 PM Eastern
U.S. manufacturing sector growth expanded in November as new orders and production increased despite supply chain constraints, the Institute for Supply Management said on Wednesday. The...
By Sean Brodrick On December 1, 202101:00 PM Eastern
I wrote a whole issue about how people panicking over the Omicron variant of COVID-19 shouldn’t be trusted with Monopoly money, and how Federal Reserve Chair Jerome Powell’s market-crippling words...
By Mike Larson On December 1, 202107:00 AM Eastern
Alarming headlines about COVID-19’s Omicron variant have jolted markets. Here’s what investors can do.
Strategic Options
Subscription
By Jon D. Markman On December 1, 202106:28 AM Eastern
It was another rough ride for bulls on Tuesday as stocks opened sharply lower. The catalyst was a Financial Times interview with the CEO at Moderna (MRNA), a leading vaccine maker. Based on...